litlas
ログインアカウント作成

Lars Lindholm

1984–2025 年に発表

74
論文数
28,899
被引用数
60
h 指数
71
i10 指数

被引用数

Lars Lindholm の年別被引用数1988 年: 被引用 1 件1989 年: 被引用 1 件1990 年: 被引用 1 件1992 年: 被引用 6 件1993 年: 被引用 12 件1994 年: 被引用 13 件1995 年: 被引用 11 件1996 年: 被引用 14 件1997 年: 被引用 26 件1998 年: 被引用 37 件1999 年: 被引用 34 件2000 年: 被引用 61 件2001 年: 被引用 90 件2002 年: 被引用 133 件2003 年: 被引用 244 件2004 年: 被引用 326 件2005 年: 被引用 299 件2006 年: 被引用 319 件2007 年: 被引用 291 件2008 年: 被引用 231 件2009 年: 被引用 175 件2010 年: 被引用 224 件2011 年: 被引用 207 件2012 年: 被引用 201 件2013 年: 被引用 196 件2014 年: 被引用 159 件2015 年: 被引用 139 件2016 年: 被引用 116 件2017 年: 被引用 108 件2018 年: 被引用 103 件2019 年: 被引用 246 件2020 年: 被引用 234 件2021 年: 被引用 250 件2022 年: 被引用 250 件2023 年: 被引用 218 件2024 年: 被引用 314 件2025 年: 被引用 171 件2026 年: 被引用 11 件1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,542 件、この内訳の 21.5%イギリス: 引用元論文 629 件、この内訳の 8.7%イタリア: 引用元論文 457 件、この内訳の 6.3%ドイツ: 引用元論文 331 件、この内訳の 4.6%オーストラリア: 引用元論文 293 件、この内訳の 4.1%中国: 引用元論文 293 件、この内訳の 4.1%カナダ: 引用元論文 278 件、この内訳の 3.9%スウェーデン: 引用元論文 273 件、この内訳の 3.8%日本: 引用元論文 224 件、この内訳の 3.1%フランス: 引用元論文 214 件、この内訳の 3%オランダ: 引用元論文 213 件、この内訳の 3%スペイン: 引用元論文 180 件、この内訳の 2.5%
0%21.5%その他 31.4%

機関

分野

  • Medicine87.1%
  • Biochemistry, Genetics and Molecular Biology3.6%
  • Health Professions2.2%
  • Economics, Econometrics and Finance1.3%
  • Nursing1.1%
  • Psychology0.6%
  • その他4.1%

トピック

  • Blood Pressure and Hypertension Studies14.6%
  • Sodium Intake and Health3.8%
  • Hormonal Regulation and Hypertension3.7%
  • Renin-Angiotensin System Studies3.5%
  • Cardiovascular Health and Disease Prevention3.2%
  • Heart Failure Treatment and Management2.7%
  • その他68.5%

共著者

全論文

検索で開く
  1. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    著者: Kazem Rahimi, Zeinab Bidel, Milad Nazarzadeh, Emma Copland, Dexter Canoy, Rema Ramakrishnan, Ana‐Catarina Pinho‐Gomes, Mark Woodward, Amanda Adler, Larry Agodoa, Ale Algra, Folkert W. Asselbergs, Nigel Beckett, Eivind Berge, Henry R. Black, Frank P. Brouwers, Morris J. Brown, Christopher J. Bulpitt, Robert P. Byington, William C. Cushman, Jeffrey A. Cutler, Richard B Devereaux, Jamie P. Dwyer, Ray Estacio, Robert Fagard, Kim Fox, Tsuguya Fukui, Ajay Gupta, Rury R. Holman, Yutaka Imai, Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, Kizuku Kuramoto, Jan Lanke, Edmund J. Lewis, Julia B. Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, Giuseppe Mancia, Masunori Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, Christopher R. Palmer, Anushka Patel, Marc Allan Pfeffer, Bertram Pitt, Neil R Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, Takao Saruta, Joachim Schrader, Robert W. Schrier, Peter Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, Lindon Wing, Yoshiki Yui, Salim Yusuf, Alberto Zanchetti, Zhen‐Yu Zhang, Craig S. Anderson, Colin Baigent, Barry M. Brenner, Rory Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi-Khorshidi, Johan Sundström, Fiona Turnbull, Giancarlo Viberti, Ji‐Guang Wang, John Chalmers, Koon Teo, Carl J. Pepine, Barry R. Davis - The Lancet 2021 被引用: 1,001

  2. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

    著者: Kazem Rahimi, Zeinab Bidel, Milad Nazarzadeh, Emma Copland, Dexter Canoy, Małgorzata Wamil, Jeannette Majert, Richard J. McManus, Amanda Adler, Larry Agodoa, Ale Algra, Folkert W. Asselbergs, Nigel Beckett, Eivind Berge, Henry R. Black, Eric Boersma, Frank P. Brouwers, Morris J. Brown, Jasper J. Brugts, Christopher J. Bulpitt, Robert P. Byington, William C. Cushman, Jeffrey A. Cutler, Richard B Devereaux, Jamie P. Dwyer, Ray Estacio, Robert Fagard, Kim Fox, Tsuguya Fukui, Ajay Gupta, Rury R. Holman, Yutaka Imai, Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, Kizuku Kuramoto, Jan Lanke, Edmund J. Lewis, Julia B. Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, Giuseppe Mancia, Masunori Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, Christopher R. Palmer, Anushka Patel, Marc Allan Pfeffer, Bertram Pitt, Neil R Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, Takao Saruta, Joachim Schrader, Robert W. Schrier, Peter Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, Lindon Wing, Mark Woodward, Yoshiki Yui, Salim Yusuf, Alberto Zanchetti, Zhen‐Yu Zhang, Craig S. Anderson, Colin Baigent, Barry M. Brenner, Rory Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi-Khorshidi, Johan Sundström, Fiona Turnbull, Giancarlo Viberti, Ji‐Guang Wang, John Chalmers, Barry R. Davis ほか 2 名 - The Lancet 2021 被引用: 321

  3. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

    著者: Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen, Stevo Julius, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister Kristiansson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel - The Lancet 2002 被引用: 5,417

  4. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

    著者: Milad Nazarzadeh, Zeinab Bidel, Dexter Canoy, Emma Copland, Derrick Bennett, Abbas Dehghan, George Davey Smith, Rury R. Holman, Mark Woodward, Ajay Gupta, Amanda Adler, Małgorzata Wamil, Naveed Sattar, William C. Cushman, Richard J. McManus, Koon Teo, Barry R. Davis, John Chalmers, Carl J. Pepine, Kazem Rahimi, Larry Agodoa, Ale Algra, Folkert W. Asselbergs, Nigel Beckett, Eivind Berge, Henry R. Black, Frank P. Brouwers, Morris J. Brown, Christopher J. Bulpitt, Bob Byington, J A Cutler, Richard B Devereaux, Jamie P. Dwyer, R Estacio, Robert Fagard, Keith A.A. Fox, Tomohiro FUKUI, Yutaka Imai, Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, K Kuramoto, Jan Lanke, Edmund J. Lewis, Julia B. Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, Giuseppe Mancia, M Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, C. Palmer, Anushka Patel, Marc Allan Pfeffer, Neil R Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, T Saruta, Joachim Schrader, Robert W. Schrier, Peter Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, Lindon Wing, Yoshiki Yui, Salim Yusuf, Alberto Zanchetti, Z Y Zhang, Craig S. Anderson, Colin Baigent, Brenner Bm, Rory Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Bertram Pitt, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi‐Khorshidi, Johan Sundström ほか 3 名 - The Lancet Diabetes & Endocrinology 2022 被引用: 102

  5. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    著者: Authors/Task Force Members:, G. Mancia, Guy De Backer, Anna F. Dominiczak, Renata Cífková, R. Fagard, Giuseppe Germanò, Guıdo Grassı, A. M. Heagerty, SE Kjeldsen, S. Laurent, Krzysztof Narkiewicz, Luís M. Ruilope, Andrzej Rynkiewicz, Roland E. Schmieder, Harry A.J. Struijker Boudier, Alberto Zanchetti, Alec Vahanian, A. John Camm, Raffaele De Caterina, V. Dean, Kenneth Dickstein, G. Filippatos, Christian Funck‐Brentano, Irene Hellemans, S. D. Kristensen, Keith McGregor, U Sechtem, Sigmund Silber, Michał Tendera, P. Widimsky, José Luis Zamorano, SE Kjeldsen, Serap Erdine, Krzysztof Narkiewicz, W. Kiowski, Enrico Agabiti‐Rosei, E Ambrosioni, Renata Cífková, Anna F. Dominiczak, R. Fagard, A. M. Heagerty, S. Laurent, Lars Lindholm, G. Mancia, Athanasios Manolis, Peter M. Nilsson, Josep Redón, Roland E. Schmieder, Harry A.J. Struijker-Boudier, Margus Viigimaa, Document Reviewers:, G. Filippatos, Stamatis Adamopoulos, Enrico Agabiti‐Rosei, E Ambrosioni, Vicente Bertoméu, D Clément, Serap Erdine, Csaba Farsang, D. Gaita, W. Kiowski, Gregory Y.H. Lip, Jean-Michel Mallion, Athanasios Manolis, Peter M. Nilsson, Eoin O’Brien, Piotr Ponikowski, Josep Redón, Frank Ruschitzka, Juan Tamargo, PA van Zwieten, Margus Viigimaa, Bernard Waeber, Bryan Williams, José Luis Zamorano - European Heart Journal 2006 被引用: 2,388

  6. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

    著者: Emma Copland, Dexter Canoy, Milad Nazarzadeh, Zeinab Bidel, Rema Ramakrishnan, Mark Woodward, John Chalmers, Koon Teo, Carl J. Pepine, Barry R. Davis, Sverre E. Kjeldsen, Johan Sundström, Kazem Rahimi, Amanda Adler, Larry Agodoa, Ale Algra, Folkert W. Asselbergs, Nigel Beckett, Eivind Berge, Henry R. Black, Frank P. Brouwers, Mark A. Brown, Christopher J. Bulpitt, Bob Byington, John Chalmers, William C. Cushman, J A Cutler, Barry R. Davis, Richard B Devereaux, Jamie P. Dwyer, R Estacio, Robert Fagard, Kim Fox, Takahiro Fukui, Ajay Gupta, Rury R. Holman, Y. Imai, Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, K Kuramoto, Jan Lanke, Edmund J. Lewis, Jeff Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, G. Mancia, M Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, C. Palmer, Anushka Patel, Carl J. Pepine, Michael Pfeffer, N. Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, T Saruta, Joachim Schrader, Robert W. Schrier, Peter S. Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, L. Wing, Mark Woodward, Yoshiaki Yui, Salim Yusuf, Alberto Zanchetti, Z Y Zhang, Craig S. Anderson, Colin Baigent, Brenner Bm, Richard Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Bertram Pitt, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi-Khorshidi ほか 4 名 - The Lancet Oncology 2021 被引用: 104

  7. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol

    著者: Kristian Wachtell, Mika Lehto, Eva Gerdts, Michael Hecht Olsen, Björn Hornestam, Björn Dahlöf, Hans Ibsen, Stevo Julius, Sverre E. Kjeldsen, Lars Lindholm, Markku S. Nieminen, Richard B. Devereux - Journal of the American College of Cardiology 2005 被引用: 827

  8. A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

    著者: Michael A. Weber, Henry R. Black, George L. Bakris, Henry Krum, Stuart L. Linas, Robert Weiss, Jennifer V. Linseman, Brian L. Wiens, Marshelle Warren, Lars Lindholm - The Lancet 2009 被引用: 331

  9. Clinical Practice Guidelines for the Management of Hypertension in the Community

    著者: Michael A. Weber, Ernesto L. Schiffrin, William B. White, Samuel J. Mann, Lars Lindholm, John G. Kenerson, John M. Flack, Barry L. Carter, Barry J. Materson, C. Venkata S. Ram, Debbie L. Cohen, Jean‐Claude Cadet, Roger R. Jean‐Charles, Sandra J. Taler, David S. Kountz, Raymond R. Townsend, John Chalmers, Agustín J. Ramiréz, George L. Bakris, Ji‐Guang Wang, Aletta E. Schutte, John D. Bisognano, Rhian M. Touyz, Dominic A. Sica, Stephen Harrap - Journal of Clinical Hypertension 2013 被引用: 1,000

  10. Divergent Results Using Clinic and Ambulatory Blood Pressures

    著者: George L. Bakris, Lars Lindholm, Henry R. Black, Henry Krum, Stuart L. Linas, Jennifer V. Linseman, Sarah Arterburn, Philip T. Sager, Michael A. Weber - Hypertension 2010 被引用: 195

  11. The impact of serum uric acid on cardiovascular outcomes in the LIFE study

    著者: Aud Høieggen, Michael H. Alderman, Sverre E. Kjeldsen, Stevo Julius, Richard B. Devereux, Ulf de Faire, Frej Fyhrquist, Hans Ibsen, Krister Kristianson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, Cong Chen, Björn Dahlöf, for the LIFE Study Group - Kidney International 2004 被引用: 476

  12. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

    著者: Lennart Hansson, Lars Lindholm, Leo Niskanen, Jan Lanke, Thomas Hedner, Anders Niklason, K Luomanmäki, Björn Dahlöf, Ulf dé Fairé, Claes Mörlin, Bengt E. Karlberg, P-O Wester, Jan-Erik Björck - The Lancet 1999 被引用: 2,012

  13. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

    著者: Björn Dahlöf, L. Hansson, Lars Lindholm, Bengt Scherstén, Tord Ekbom, P-O Wester - The Lancet 1991 被引用: 1,893

  14. Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis

    著者: Lars Lindholm, Bo Carlberg, Ola Samuelsson - The Lancet 2005 被引用: 993

  15. Systolic pressure is all that matters

    著者: Bryan Williams, Lars Lindholm, Peter Sever - The Lancet 2008 被引用: 197

  16. Mobile App for Treatment of Stress Urinary Incontinence: A Cost-Effectiveness Analysis

    著者: Malin Sjöström, Lars Lindholm, Eva Samuelsson - Journal of Medical Internet Research 2017 被引用: 89

  17. The burden of high workload on the health-related quality of life among home care workers in Northern Sweden

    著者: André Sjöberg, Anita Pettersson-Strömbäck, Klas-Göran Sahlèn, Lars Lindholm, Fredrik Norström - International Archives of Occupational and Environmental Health 2020 被引用: 56

  18. Estimating a social value set for EQ-5D-5L in Sweden

    著者: Sun Sun, Ling‐Hsiang Chuang, Klas-Göran Sahlèn, Lars Lindholm, Fredrik Norström - Health and Quality of Life Outcomes 2022 被引用: 34

  19. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

    著者: Lars Lindholm, Hans Ibsen, Björn Dahlöf, Richard B. Devereux, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Stevo Julius, Sverre E. Kjeldsen, Krister Kristiansson, Ole Lederballe‐Pedersen, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, Peter Aurup, Jonathan M. Edelman, Steven Snapinn - The Lancet 2002 被引用: 1,571

  20. Atenolol in hypertension: is it a wise choice?

    著者: Bo Carlberg, Ola Samuelsson, Lars Lindholm - The Lancet 2004 被引用: 568

  21. Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy and Reduction in Sudden Cardiac Death

    著者: Kristian Wachtell, Peter M. Okin, Michael Hecht Olsen, Björn Dahlöf, Richard B. Devereux, Hans Ibsen, Sverre E. Kjeldsen, Lars Lindholm, Markku S. Nieminen, Kristian Thygesen - Circulation 2007 被引用: 226

  22. Delay to celiac disease diagnosis and its implications for health-related quality of life

    著者: Fredrik Norström, Lars Lindholm, Olof Sandström, Katrina Nordyke, Anneli Ivarsson - BMC Gastroenterology 2011 被引用: 173

  23. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

    著者: Lennart Hansson, Lars Lindholm, Tord Ekbom, Björn Dahlöf, Jan Lanke, Bengt Scherstén, P-O Wester, Thomas Hedner, Ulf dé Fairé - The Lancet 1999 被引用: 1,448

  24. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

    著者: Lennart Hansson, Thomas Hedner, Per Lund‐Johansen, Sverre E. Kjeldsen, Lars Lindholm, Jan Otto Syvertsen, Jan Lanke, Ulf dé Fairé, Björn Dahlöf, Bengt E. Karlberg - The Lancet 2000 被引用: 902